Adenosine Pathway Clinical Trial Landscape Infographic
Our Beacon Checkpoint research team and the producers of the 2023 Adenosine-Targeted Cancer Immunotherapies Summit have carefully crafted this free infographic to provide you with a deep dive into the adenosine-pathway clinical trial landscape, using data from the Beacon Checkpoint database.
The data in this infographic reviews:
The number of adenosine-pathway targeted therapies entering the clinic since 2011.
Status and modalities of adenosine-pathway targeted therapies.
Clinical trials by phase over the years.
Top disease indications.
You May Also Be Interested In…
What is Beacon?
Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements
